TY - JOUR

T1 - The Hopkins-Oxford Psychedelics Ethics (HOPE) Working Group Consensus Statement

AU - Jacobs, Edward

AU - Earp, Brian D

AU - Appelbaum, Paul S

AU - Bruce, Lori

AU - Cassidy, Ksenia

AU - Celidwen, Yuria

AU - Cheung, Katherine

AU - Clancy, Sean K

AU - Devenot, Neşe

AU - Evans, Jules

AU - Lynch, Holly Fernandez

AU - Friesen, Phoebe

AU - Romeu, Albert Garcia

AU - Gehani, Neil

AU - Maloof, Molly

AU - Marcus, Olivia

AU - Martin Moen, Ole

AU - Mertens, Mayli

AU - Nayak, Sandeep M

AU - Noorani, Tehseen

AU - Patch, Kyle

AU - Porsdam-Mann, Sebastian

AU - Raj, Gokul

AU - Rajwani, Khaleel

AU - Ray, Keisha

AU - Smith, William

AU - Villiger, Daniel

AU - Levy, Neil

AU - Crisp, Roger

AU - Savulescu, Julian

AU - Singh, Ilina

AU - Yaden, David B

PY - 2024/5/2

Y1 - 2024/5/2

N2 - The first Hopkins-Oxford Psychedelic Ethics (HOPE) workshop convened to discuss ethical matters relating to psychedelics in August 2023 at the University of Oxford.The organizers (BDE, DBY, EJ) aimed for a diversity of participant backgrounds and perspectives. The keynotes were given by an Indigenous scholar and a psychiatrist; other attendees included lawyers and ethicists, psychedelic scientists, anthropologists, philosophers, entrepreneurs, and harm reduction actors.The workshop was organized out of a recognition that the field of psychedelics is at a pivotal point in its history: Research, clinical applications, and policy initiatives are quickly scaling up. The use of psychedelics is expanding, and the development of new systems governing their use is already underway. These changes are happening while substantial uncertainty remains, both about the effects of psychedelics and about the ethical dimensions surrounding their use. We recognize that there is a significant risk of harms, as well as potential benefits. Participants at the workshop discussed the ethical aspects of psychedelics, including research methods, clinical practices, history, law and society, spirituality, community, culture, and politics that arise in relation to psychedelics.

AB - The first Hopkins-Oxford Psychedelic Ethics (HOPE) workshop convened to discuss ethical matters relating to psychedelics in August 2023 at the University of Oxford.The organizers (BDE, DBY, EJ) aimed for a diversity of participant backgrounds and perspectives. The keynotes were given by an Indigenous scholar and a psychiatrist; other attendees included lawyers and ethicists, psychedelic scientists, anthropologists, philosophers, entrepreneurs, and harm reduction actors.The workshop was organized out of a recognition that the field of psychedelics is at a pivotal point in its history: Research, clinical applications, and policy initiatives are quickly scaling up. The use of psychedelics is expanding, and the development of new systems governing their use is already underway. These changes are happening while substantial uncertainty remains, both about the effects of psychedelics and about the ethical dimensions surrounding their use. We recognize that there is a significant risk of harms, as well as potential benefits. Participants at the workshop discussed the ethical aspects of psychedelics, including research methods, clinical practices, history, law and society, spirituality, community, culture, and politics that arise in relation to psychedelics.

U2 - 10.1080/15265161.2024.2342764

DO - 10.1080/15265161.2024.2342764

M3 - Journal article

C2 - 38695382

JO - American Journal of Bioethics

JF - American Journal of Bioethics

SN - 1526-5161

ER -